Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation, an Open Label Randomized Controlled Trial

NCT06462989 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT06462989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06462989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation, an Open Label Randomized Controlled Trial
Lead sponsor
Montreal Heart Institute
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 16, 2025
Completion date
December 31, 2027
Enrollment
5,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

structural heart abnormality, structural heart disease